Pharmacokinetics (PK) and pharmacodynamics (PD) are the two main areas of integrative pharmacology. PK evaluates 'what the body does to the drug' (absorption, metabolism, distribution and excretion of drugs), and PD studies 'what the drug does to the body' (biological effects of drugs over time, the relationship between drug exposure and effects, mechanism of action of drugs). The primary purpose of PK and PD modeling is to discover the biophysiological key properties of the drug (affinity, efficacy, potency and specific systemic factor), and to predict the time course and extent of drug effect under normal physiological condition, as well as specific pathological conditions [1,2]. Usually, PK studies are first performed in various in vitro and in vivo environments, and then the concentration-effect/dose-effect relationship is inferred. To identify a meaningful PK-PD relationship, it is important to fully correlate the pharmacological effect with the drug concentration of the appropriate compartment in vivo [3-5]. In this process, if hysteresis (a time lag between the measured concentration and the observed effect) is demonstrated, several PK-PD modeling approaches, such as effect compartment link model, turnover model/indirect response model, and tolerance/ rebound model, can be employed to describe it [3,6,7]. This paper introduces the semi-compartmental model, one method to collapse the hysteresis in the PK-PD relationship.
INTRODUCTION
Frequently, we encounter the phenomenon of hysteresis in kinetic-dynamic modeling. The hysteresis loop in the concentration-effect curve suggests a time discrepancy caused by various pharmacokinetic and pharmacodynamic factors. To collapse the hysteresis loop and to simplify the concentration-effect relationship, several kinetic-dynamic modeling approaches including the effect compartment link model, turnover model (indirect response model), and tolerance/rebound model, have been used. The semicompartmental model is one method to describe the hysteresis of the pharmacokineticpharmacodynamic relationship. Furthermore, this semi-compartmental model differs from other models (full parametric approaches) as it does not require pharmacokinetic parameters to estimate pharmacodynamic parameters and k e0 . Therefore, we could employ a semi-compartmental approach in case it is difficult to apply the compartment model to pharmacokinetic data, as required for the pharmacodynamic analysis of inhalational anesthetics.
Keywords: Hysteresis; Pharmacodynamics; Pharmacokinetics; Pharmacology; Semicompartmental model. [3, 4] . Compartmental PK models, that simplify complex organs and tissues into compartments and connecting lines, are most widely used [8, 9] . Fig. 1 shows a three-compartment model.
PHARMACODYNAMICS
The PD model relates the drug concentration provided by the PK model to the observed drug effect [2, 3, 5, 7] . The most commonly used PD model for describing the non-linear concentration-effect relationship is the sigmoid E max model (the Hill equation [7, 10] , Eq. 1):
where E is effect, C is drug concentration, E max is the maximum effect, EC 50 is the concentration of the drug producing half of E max and n is the so-called steepness factor (n does not necessarily have a direct biological meaning, but it determines the slope of the curve. In the ordinary E max model, n is equal to 1). This model can be used extensively in other areas;
for example, in the receptor theory, EC 50 reflects the potency of the drug in the system (the sensitivity of the organ or tissue to the drug) and E max is the efficacy of the drug. If n is less than 1, the curve becomes hyperbolic, implying active metabolites or multiple receptor sites [5, 7] . 
KINETIC-DYNAMIC (PK-PD) MODELING
Since PK and PD models share a common feature, i.e. concentration, they can be integrated to describe the overall dose-effect relationship, leading to useful insights into rational dose regimen design ( Fig. 3 ) [3] [4] [5] . In the direct link model ics and neuromuscular blockers produce a peak in the blood in a short time; however, no tracheal intubation is concurrently performed since while the drug plasma concentration reaches its maximum, further time is required for the drug to reach its maximum at the effect site. As observed, when a distribution delay between the plasma concentration and the effect site concentration (hysteresis) appears, the plasma concentration fails to represent the effect site concentration (drug effect).
WHAT IS HYSTERESIS IN THE PK-PD RELATIONSHIP?
Hysteresis is a phenomenon that occur occasionally in PK-PD modeling. Hysteresis can be easily comprehended by utilizing visual thinking. When the concentration-effect curve is drawn ( Fig. 5 ), the hysteresis loop can be observed. If you draw a vertical line at the 'concentration' axis in Fig. 5 , the line crosses the curve at 2 points, indicating two different response levels for a single drug concentration. Counter-clockwise (anti-clockwise) hysteresis implies that the observed drug effect increases over time for a given drug concentration;
in clockwise hysteresis, the observed drug effect decreases over time for a given drug concentration [4, 6] .
The hysteresis loop suggests that there is a time discrepancy in the relationship between the measured drug con- 
EFFECT COMPARTMENT LINK MODEL
The effect compartment link model was elaborated by Holford and Sheiner [4, 12, 13] based on the concept of Segre [14] . 
SEMI-COMPARTMENTAL MODEL
The semi-compartmental model is another estimation method that can be used to collapse hysteresis of the PK-PD relationship, deriving the solution for the effect site concentration from the effect compartment link model. There are two different solutions used in the semi-compartmental model: linear solution and log-linear solution [7, 15] (In 'NONMEM', a linear solution is applied when the plasma concentration is increased, and the log-linear solu-tion is applied when the plasma concentration is decreased.
The control file for the semi-compartmental modeling used in 'NONMEM' is presented in the Appendix 1).
In the linear semi-compartmental solution, the plasma concentration (C p ) obtained by assuming a piecewise linear PK model is expressed as Eq. 5.
The integration of Eq. 3 defined the C p -C e relationship and Eq. 5 yields the solution for concentration at the effect site (C e ) given as Eq. 6:
C e = C e · e −ke0(tj − tj − 1) + k e0 C pj − 1 {e −λj(tj − tj − 1) − e −ke0(tj − tj − 1) } k e0 − λ j (Eq. 6)
In the log-linear semi-compartmental solution, the plasma concentration (C p ) is expressed in exponential form as Eq. 7, assuming a piecewise log-linear PK model. C p = C pj − 1 + e −λj (t − tj − 1) where λ j = lnC pj − lnC pj − 1 t j − t j − 1 Additionally, the log-linear semi-compartmental solution for effect site concentration (C e ) is derived from the integration of Eq. 3 and Eq. 7, like the linear solution, and the equation is as below Eq. 8.
C e = C e · e −ke0(tj − tj − 1) + (Eq. 8)
Given the observed values for C p , an estimate of k e0 , and starting the recursive formula with C p (0) = C e = 0 (at time zero, the plasma and effect site concentrations are both zero), the time curve for C e can be obtained from Eq. 6 and Eq. 8.
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